Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | RXRA | P19793 | 1/20 | 0.64 |
| ▸ | RXRB | P28702 | 1/20 | 0.64 |
| ▸ | RXRG | P48443 | 1/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25172929 | 0.98 | HSD17B10 (0.65) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL12812658 | 0.94 | HSD17B10 (0.61) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL1066202 | 0.94 | MAPT (0.66) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL1139126 | 0.94 | MAPT (0.66) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL11295813 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL712374 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL878982 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL25167628 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL11291327 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL8002906 | 0.92 | MAPT (0.69) | SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058844-A | TGM2 specific binding near infrared probe and application thereof | 中国人民解放军空军军医大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4545098-A1 | FIBROBLAST ACTIVATION PROTEIN COMPOUND OR SALT WITH ALBUMIN DUAL-BINDING FUNCTION | National Atomic Research Institute (TW) | 2025-04-30 | — | — | EP | claimed |
| CN-118146304-A | Polypeptide compound and application of solid tumor diagnosis and treatment | 中国人民解放军空军军医大学 | 2024-06-07 | — | — | CN | claimed |
| CN-116271116-A | 68 Ga-marked Exendin 4 radioactive probe with improved structure and preparation method thereof | 北京师范大学 | 2023-06-23 | — | — | CN | claimed |
| US-20220395478-A1 | METHODS FOR MODIFYING ENDOPLASMIC RETICULUM PROCESSING OF PROTEIN | MEMORIAL SLOAN KETTERING CANCER CENTER | 2022-12-15 | — | — | US | claimed |
| CN-113117099-B | PSMA (patterned beam-induced fluorescence) targeted fluorescent molecular probe as well as preparation method and application thereof | 广东精观生物医药科技有限公司 | 2022-07-15 | — | — | CN | claimed |
| WO-2022134551-A1 | PSMA-TARGETED FLUORESCENT MOLECULAR PROBE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 广东精观生物医药科技有限公司 | 2022-06-30 | — | — | WO | claimed |
| US-20220089574-A1 | CXCR4 gamete molecular structure and method thereof | LI MING HSIN (TW) | 2022-03-24 | — | — | US | claimed |
| CN-113117099-A | PSMA (patterned beam-induced fluorescence) targeted fluorescent molecular probe as well as preparation method and application thereof | 广东精观生物医药科技有限公司 | 2021-07-16 | — | — | CN | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| WO-2019067061-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| EP-3397738-A1 | HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF | ExxonMobil Research and Engineering Company (US) | 2018-11-07 | — | — | EP | claimed |
| US-20180119045-A1 | HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2018-05-03 | — | — | US | claimed |
| WO-2017116900-A1 | HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-07-06 | — | — | WO | claimed |
| CN-1886363-A | Amino acids with affinity for the alpha2delta-protein | WARNER LAMBERT CO (US) | 2006-12-27 | — | — | CN | claimed |
| EP-4743125-A1 | METHOD OF TREATING PROSTATE CANCER | Novartis AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-0440995-A1 | Process for preparing 1-octene | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-08-14 | — | — | EP | disclosed |
| US-5030792-A | Process for preparing 1-octene | SHELL OIL COMPANY (US) | 1991-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | SMN1; SMN2 853/4885HDAC3 4338/4885MAPK1 3582/4885 |
| US-20220089574-A1 | CXCR4 gamete molecular structure and method thereof | CXCR4, CXCR1, CXCL12 | SMN1; SMN2 4682/4885HDAC3 3503/4885MAPK1 2026/4885 |
| US-20220395478-A1 | METHODS FOR MODIFYING ENDOPLASMIC RETICULUM PROCESSING OF PROTEIN | HSPA5, VCP, ERP44 | SMN1; SMN2 3062/4885HDAC3 3286/4885MAPK1 3549/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | SMN1; SMN2 853/4885HDAC3 4338/4885MAPK1 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.